阿尼卡疗法 ANIK 深 沪
已收盘 05-08 16:00:00 美东时间
14.77
-0.370
-2.44%
华盛通- 最 高15.3599
- 今 开15.10
- 成交量 11.07万股
- 最 低 14.76
- 昨 收 15.14
- 总市值 1.97亿
- 52周最高 16.24
- 市盈率 静 --
- 换手率 0.83%
- 52周最低 7.8701
- 委 比 86.78%
- 总股本 1330.56万
- 历史最高 75.715
- 量 比 0.80
- 振 幅 3.96%
- 历史最低 5.24
- 每 手 1
- 风险率 2.12%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Analysts Offer Insights on Healthcare Companies: Opus Genetics (IRD), Anika Therapeutics (ANIK) and Insulet (PODD)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
04-30 21:51
Anika Therapeutics Signals Momentum Amid Regulatory Hurdles
Anika Therapeutics, Inc. (($ANIK)) has held its Q1 earnings call. Read on for t...
04-30 08:51
Anika Therapeutics shares are trading lower. The company reported Q1 financial results.
Anika Therapeutics shares are trading lower. The company reported Q1 financial ...
04-30 00:44
Earnings Scheduled For April 29, 2026
Companies Reporting Before The Bell • Extreme Networks (NASDAQ:EXTR) is likely ...
04-29 19:11
Anika Therapeutics Affirms FY2026 Sales Guidance of $114.000M-$122.500M vs $117.220M Est
Anika Therapeutics (NASDAQ:ANIK) affirms FY2026 sales outlook from $114.000 million-$122.500 million to $114.000 million-$122.500 million vs $117.220 million estimate.
04-29 19:08
Anika Therapeutics Q1 Adj. EPS $0.27 Beats $(0.16) Estimate, Sales $29.612M Beat $28.142M Estimate
Anika Therapeutics (NASDAQ:ANIK) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $(0.16) by 268.75 percent. This is a 550 percent increase over losses of $(0.06) per share from
04-29 19:07
Xilio Therapeutics names Cheryl Blanchard to board of directors
Xilio Therapeutics names Cheryl Blanchard to board of directors Xilio Therapeutics appointed Cheryl R. Blanchard to board of directors. Blanchard is executive chair at Anika Therapeutics; previously served as its president and CEO. Her prior roles include president and CEO of Microchips Biotech thro
04-16 19:35
